Jeffrey S. Scehnet, Ph.D.
Affiliations: | 2010 | Pathobiology | University of Southern California, Los Angeles, CA, United States |
Area:
Molecular BiologyGoogle:
"Jeffrey Scehnet"Parents
Sign in to add mentor| Parkash S. Gill | grad student | 2010 | USC | |
| (Targeting vessel maturation: An anti-angiogenesis based cancer therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Krasnoperov V, Kumar SR, Ley E, et al. (2010) Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. The American Journal of Pathology. 176: 2029-38 |
| Liu R, Li X, Tulpule A, et al. (2010) KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 115: 887-95 |
| Kumar SR, Scehnet JS, Ley EJ, et al. (2009) Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Research. 69: 3736-45 |
| Scehnet JS, Ley EJ, Krasnoperov V, et al. (2009) The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 113: 254-63 |
| Trindade A, Kumar SR, Scehnet JS, et al. (2008) Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood. 112: 1720-9 |
| Kumar SR, Masood R, Spannuth WA, et al. (2007) The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. British Journal of Cancer. 96: 1083-91 |
| Scehnet JS, Jiang W, Kumar SR, et al. (2007) Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 109: 4753-60 |
| Kumar SR, Singh J, Xia G, et al. (2006) Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. The American Journal of Pathology. 169: 279-93 |